Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion A case study for pembrolizumab and daratumumab
Fields of Study & Subjects
Pharmaceutical Economics and Policy
Health Systems
Economic Evaluations
Quality of Life
Economic and Financial Impacts of Cancer
Publication details
- Journal / source
- OSF Preprints (OSF Preprints)
- Publication date
- 15 January 2026
- Document type
- Preprint